In Situ Simulation Training in Transferring Critically Ill COVID-19 Patients
November 8, 2021 updated by: Aida Rosita Tantri, Indonesia University
In Situ Simulation Training for a Better Interprofessional Team Performance in Transferring Critically Ill COVID-19 Patients: A Prospective Randomized Control Trial
This study aimed to determine the role of in situ simulation training during a pandemic by using standard and high-fidelity mannequins to improve interprofessional communication, skills, and teamwork in transferring critically ill COVID-19 patients.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Fourty subjects were randomly allocated into two large groups, the High Fidelity Simulator group and the Low Fidelity Simulator group.
Each group was divided into small groups, consist of 2 doctors and 3 nurses.
All subjects underwent the same interactive lectures, and two sessions of in-situ simulation according to their assign group.
In-situ simulation and debriefing were performed by implementing appropriate personal protective equipment and social distancing.
At the end of each simulation session, each group would underwent a debriefing session, which was performed by an experience instructor.
The first simulation was aimed to teach participants skills and steps in transporting critically-ill COVID-19 patients according to the hospital check-list.
While the second simulation was aimed to assess skills, team work and communication that participants had learned from the previous simulation, by using assessment tools that had been developed before.
In addition to comparing each point in the assessment tool between the two groups, the points that had been earned were also added up to get the overall points for total skills, cooperation and communication score.
At the end of the session, learner immediate feedback were also collected using an online feedback form, which provided accountability for attendance, content learning, and course evaluation feedback.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
DKI Jakarta
-
Jakarta, DKI Jakarta, Indonesia, 10430
- Cipto Mangunkusumo Cental National Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- in good physical condition
- had no history of involving in COVID-19 patients care
- willing to become study subject
Exclusion Criteria:
- doesn't want to become study subject
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: High Fidelity Simulator
Subjects will receive training using high fidelity simulator
|
Simulation Training using High and Low Fidelity Simulator
|
|
Active Comparator: Low Fidelity Simulator
Subjects will receive training using low fidelity simulator
|
Simulation Training using High and Low Fidelity Simulator
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
rate of interprofessional communication
Time Frame: within 3 months
|
improvement of interprofessional communication in transferring critically ill COVID-19 patients
|
within 3 months
|
|
rate of skill
Time Frame: within 3 months
|
improvement of skill in transferring critically ill COVID-19 patients
|
within 3 months
|
|
rate of team work
Time Frame: within 3 months
|
improvement of team work in transferring critically ill COVID-19 patients
|
within 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 16, 2020
Primary Completion (Actual)
November 19, 2020
Study Completion (Actual)
March 15, 2021
Study Registration Dates
First Submitted
October 25, 2021
First Submitted That Met QC Criteria
November 8, 2021
First Posted (Actual)
November 9, 2021
Study Record Updates
Last Update Posted (Actual)
November 9, 2021
Last Update Submitted That Met QC Criteria
November 8, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IndonesiaUAnes122
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.